Evicenter
Ubrelvy (ubrogepant) in Acute treatment of migraine
Manufacturer
AbbVie Inc.
Prescribing information
Ubrelvy (opens in a new tab)
Questions
59
Last updated

All questions

Safety: Ubrelvy (ubrogepant) in acute treatment of migraine

9 questions · 2 sources

Safety evidence

Does Ubrelvy prolong the QT interval?

Side effects

What side effects occurred when Ubrelvy was taken during the prodrome?

Note: After nausea, each pair of percentages is UBRELVY 100 mg followed by placebo. The Ubrelvy Prescribing Information does not describe this study.

What are the most common side effects of Ubrelvy?

Note: Table 2 columns are placebo (N=984), UBRELVY 50 mg (N=954), and UBRELVY 100 mg (N=485), in that order (% of patients).

Does Ubrelvy cause drowsiness or fatigue?

Note: The Somnolence row of Table 2 gives placebo, UBRELVY 50 mg, and UBRELVY 100 mg, in that order (% of patients in Studies 1 and 2). The last passage is from the Patient Information printed with the Prescribing Information.

What are the long-term side effects of Ubrelvy?

Warnings

Who should not take Ubrelvy (contraindications)?

Can Ubrelvy cause allergic reactions?

Can Ubrelvy raise blood pressure?

Note: The label describes postmarketing reports for the CGRP antagonist class, including Ubrelvy; the last passage is from the Postmarketing Experience section of the label.

Can Ubrelvy cause Raynaud's phenomenon?

Note: The label describes postmarketing reports for the CGRP antagonist class, including Ubrelvy; the symptom-onset figure is from reported cases with small molecule CGRP antagonists. The last passage is from the Postmarketing Experience section of the label.